Supernus Pharmaceuticals, Inc.
DE ˙ DB ˙ US8684591089
37,80 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:S49 / Supernus Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership331 shares
Latest Disclosed Value $ 16,451
Group One Trading, L.p. ownership in S49 / Supernus Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 331 shares of Supernus Pharmaceuticals, Inc. (DE:S49) valued at $14,299 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 2,790 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of -88.14% during the quarter. The current value of the position is $12,512 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (S49) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 6,300 of underlying shares valued at $313,110 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:S49 / Supernus Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 331 -2,459 -88.14 16 -87.97 0.0000
2025-11-12 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 2,790 2,790 133 0.0002
2024-05-10 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -852 -100.00 0 -100.00
2024-02-14 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 852 852 25 0.0001
2023-08-09 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -113 -100.00 0 -100.00
2023-05-12 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 113 -1,386 -92.46 4 -92.45 0.0000
2023-02-09 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,499 -29,197 -95.12 53 -94.90 0.0001
2022-11-09 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 30,696 -30,576 -49.90 1,039 -41.37 0.0020
2022-08-11 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 61,272 59,984 4,657.14 1,772 4,119.05 0.0028
2022-05-12 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,288 -1,200 -48.23 42 -42.47 0.0000
2022-02-11 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 2,488 -1,851 -42.66 73 -37.07 0.0001
2021-11-12 2021-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 4,339 4,339 116 0.0001
2021-08-10 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -1,584 -100.00 0 -100.00
2021-05-12 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,584 839 112.62 41 115.79 0.0001
2021-02-10 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 745 -517 -40.97 19 -26.92 0.0000
2020-11-12 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,262 -10,288 -89.07 26 -90.51 0.0001
2020-08-13 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 11,550 -11,376 -49.62 274 -33.50 0.0013
2020-05-13 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 22,926 -58,334 -71.79 412 -78.62 0.0033
2020-02-10 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 81,260 70,842 680.00 1,927 573.78 0.0131
2019-11-12 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 10,418 5,204 99.81 286 65.32 0.0023
2019-08-09 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 5,214 -260 -4.75 173 -9.90 0.0016
2019-05-14 2019-03-31 13F/A-1 SUPERNUS PHARMACEUTICALS COM 868459108 5,474 -10,883 -66.53 192 -64.64 0.0021
2019-05-13 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 5,474 -10,883 192
2019-02-05 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 16,357 14,165 646.21 543 393.64 0.0047
2018-11-08 2018-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 2,192 2,192 110 0.0009
2018-05-16 2018-03-31 13F/A-1 SUPERNUS PHARMACEUTICALS COM 868459108 0 -456 -100.00 0 -100.00
2018-02-09 2017-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 456 -452 -49.78 18 -50.00 0.0001
2017-11-15 2017-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 908 908 36 0.0003
2017-05-10 2017-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -7,471 -100.00 0 -100.00
2017-02-15 2016-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 7,471 7,471 189 0.0018
2016-08-12 2016-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -8,986 -100.00 0 -100.00
2016-05-12 2016-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 8,986 8,986 137 0.0019
2014-10-31 2014-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -89,882 -100.00 0 -100.00
2014-08-12 2014-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 89,882 -239,919 -72.75 984 -66.62 0.0152
2014-05-07 2014-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 329,801 130,528 65.50 2,948 96.14 0.0496
2014-01-31 2013-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 199,273 199,273 1,503 0.0227
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 1,800 -30.77 86 6.17 n/a n/a n/a
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 2,600 -70.45 82 -71.87 n/a n/a n/a
2025-05-14 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 8,800 76.00 288 60.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A SUPERNUS PHARMACEUTICALS COM Call 5,000 194.12 181 239.62 n/a n/a n/a
2025-02-14 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 5,000 181 n/a n/a n/a
2024-11-14 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 1,700 53 n/a n/a n/a
2024-05-10 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 900 800.00 26 1,200.00 n/a n/a n/a
2023-11-09 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 100 3 n/a n/a n/a
2022-11-09 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-11 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 300 0.00 9 -10.00 n/a n/a n/a
2022-05-12 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 300 0.00 10 11.11 n/a n/a n/a
2022-02-11 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 300 -57.14 9 -52.63 n/a n/a n/a
2021-11-12 2021-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 700 -89.71 19 -90.91 n/a n/a n/a
2021-08-10 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 6,800 300.00 209 364.44 n/a n/a n/a
2021-05-12 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 1,700 -26.09 45 -22.41 n/a n/a n/a
2021-02-10 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 2,300 283.33 58 346.15 n/a n/a n/a
2020-11-12 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 600 -98.65 13 -98.77 n/a n/a n/a
2020-08-13 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 44,400 -28.16 1,055 -5.13 n/a n/a n/a
2020-05-13 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 61,800 110.92 1,112 60.00 n/a n/a n/a
2020-02-10 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 29,300 -71.47 695 -75.37 n/a n/a n/a
2019-11-12 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 102,700 310.80 2,822 241.23 n/a n/a n/a
2019-08-09 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 25,000 4.60 827 -1.19 n/a n/a n/a
2019-05-14 2019-03-31 13F/A SUPERNUS PHARMACEUTICALS COM Call 23,900 109.65 837 120.84 n/a n/a n/a
2019-05-13 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 23,900 837 n/a n/a n/a
2019-02-05 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 11,400 -8.06 379 -39.26 n/a n/a n/a
2018-11-08 2018-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 12,400 -29.14 624 -40.40 n/a n/a n/a
2018-08-13 2018-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 17,500 337.50 1,047 472.13 n/a n/a n/a
2018-05-16 2018-03-31 13F/A SUPERNUS PHARMACEUTICALS COM Call 4,000 -13.04 183 0.00 n/a n/a n/a
2018-05-10 2018-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 4,000 183 n/a n/a n/a
2018-02-09 2017-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 4,600 -90.34 183 -90.39 n/a n/a n/a
2017-11-15 2017-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 47,600 -16.49 1,904 -22.51 n/a n/a n/a
2017-08-14 2017-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 57,000 -25.10 2,457 3.15 n/a n/a n/a
2017-05-10 2017-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 76,100 238.22 2,382 319.37 n/a n/a n/a
2017-02-15 2016-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 22,500 -21.33 568 -19.66 n/a n/a n/a
2016-11-14 2016-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 28,600 -41.87 707 -29.44 n/a n/a n/a
2016-08-12 2016-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 49,200 -1.01 1,002 32.19 n/a n/a n/a
2016-05-12 2016-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 49,700 -33.29 758 -24.28 n/a n/a n/a
2016-02-11 2015-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 74,500 -9.48 1,001 -13.33 n/a n/a n/a
2015-11-20 2015-09-30 13F/A SUPERNUS PHARMACEUTICALS COM Call 82,300 26.42 1,155 4.52 n/a n/a n/a
2015-11-06 2015-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 82,300 634 n/a n/a n/a
2015-08-11 2015-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 65,100 -50.53 1,105 -30.55 n/a n/a n/a
2015-05-14 2015-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 131,600 22.76 1,591 78.76 n/a n/a n/a
2015-02-11 2014-12-31 13F SUPERNUS PHARMACEUTICALS COM Call 107,200 -7.90 890 -12.06 n/a n/a n/a
2014-10-31 2014-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 116,400 6.59 1,012 -15.38 n/a n/a n/a
2014-08-12 2014-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 109,200 32.20 1,196 62.06 n/a n/a n/a
2014-05-07 2014-03-31 13F SUPERNUS PHARMACEUTICALS COM Call 82,600 -89.87 738 -87.65 n/a n/a n/a
2013-11-15 2013-09-30 13F SUPERNUS PHARMACEUTICALS COM Call 815,400 544.08 5,977 634.28 n/a n/a n/a
2013-08-02 2013-06-30 13F SUPERNUS PHARMACEUTICALS COM Call 126,600 814 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 6,300 313 n/a n/a n/a
2025-11-12 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 400 -20.00 13 -25.00 n/a n/a n/a
2025-05-14 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 500 16 n/a n/a n/a
2023-02-09 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 72,500 0.14 2,454 17.19 n/a n/a n/a
2022-08-11 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 72,400 218.94 2,094 185.29 n/a n/a n/a
2022-05-12 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 22,700 -5.42 734 4.86 n/a n/a n/a
2022-02-11 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 24,000 1,311.76 700 1,455.56 n/a n/a n/a
2021-11-12 2021-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 1,700 -19.05 45 -30.77 n/a n/a n/a
2021-08-10 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 2,100 -69.12 65 -63.48 n/a n/a n/a
2021-05-12 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 6,800 70.00 178 76.24 n/a n/a n/a
2021-02-10 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 4,000 -2.44 101 18.82 n/a n/a n/a
2020-11-12 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 4,100 -88.29 85 -89.77 n/a n/a n/a
2020-08-13 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 35,000 -30.28 831 -7.97 n/a n/a n/a
2020-05-13 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 50,200 -66.15 903 -74.33 n/a n/a n/a
2020-02-10 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 148,300 5.25 3,518 -9.14 n/a n/a n/a
2019-11-12 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 140,900 1,084.03 3,872 882.74 n/a n/a n/a
2019-08-09 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 11,900 -46.88 394 -49.81 n/a n/a n/a
2019-05-14 2019-03-31 13F/A SUPERNUS PHARMACEUTICALS COM Put 22,400 20.43 785 27.02 n/a n/a n/a
2019-05-13 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 22,400 785 n/a n/a n/a
2019-02-05 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 18,600 4.49 618 -31.03 n/a n/a n/a
2018-11-08 2018-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 17,800 -15.24 896 -28.72 n/a n/a n/a
2018-08-13 2018-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 21,000 79.49 1,257 134.51 n/a n/a n/a
2018-05-16 2018-03-31 13F/A SUPERNUS PHARMACEUTICALS COM Put 11,700 134.00 536 169.35 n/a n/a n/a
2018-05-10 2018-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 11,700 536 n/a n/a n/a
2018-02-09 2017-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 5,000 -82.70 199 -82.79 n/a n/a n/a
2017-11-15 2017-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 28,900 -44.21 1,156 -48.23 n/a n/a n/a
2017-08-14 2017-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 51,800 28.22 2,233 76.52 n/a n/a n/a
2017-05-10 2017-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 40,400 44.29 1,265 78.93 n/a n/a n/a
2017-02-15 2016-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 28,000 -29.11 707 -27.64 n/a n/a n/a
2016-11-14 2016-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 39,500 -28.44 977 -13.08 n/a n/a n/a
2016-08-12 2016-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 55,200 40.46 1,124 87.65 n/a n/a n/a
2016-05-12 2016-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 39,300 -39.35 599 -31.23 n/a n/a n/a
2016-02-11 2015-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 64,800 -17.77 871 -21.25 n/a n/a n/a
2015-11-20 2015-09-30 13F/A SUPERNUS PHARMACEUTICALS COM Put 78,800 12.73 1,106 -6.82 n/a n/a n/a
2015-11-06 2015-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 78,800 300 n/a n/a n/a
2015-08-11 2015-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 69,900 -41.11 1,187 -17.28 n/a n/a n/a
2015-05-14 2015-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 118,700 342.91 1,435 546.40 n/a n/a n/a
2015-02-11 2014-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 26,800 -14.92 222 -18.98 n/a n/a n/a
2014-10-31 2014-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 31,500 -75.92 274 -80.87 n/a n/a n/a
2014-08-12 2014-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 130,800 -61.78 1,432 -53.19 n/a n/a n/a
2014-05-07 2014-03-31 13F SUPERNUS PHARMACEUTICALS COM Put 342,200 182.58 3,059 235.05 n/a n/a n/a
2014-01-31 2013-12-31 13F SUPERNUS PHARMACEUTICALS COM Put 121,100 118.99 913 125.43 n/a n/a n/a
2013-11-15 2013-09-30 13F SUPERNUS PHARMACEUTICALS COM Put 55,300 54.47 405 76.09 n/a n/a n/a
2013-08-02 2013-06-30 13F SUPERNUS PHARMACEUTICALS COM Put 35,800 230 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.